- Molecular NameTioconazole
- SynonymTioconazol [INN-Spanish]; Tioconazolum [INN-Latin]
- Weight387.718
- Drugbank_IDDB01007
- ACS_NO65899-73-2
- Show 2D model
- LogP (experiment)4.971
- LogP (predicted, AB/LogP v2.0)5.24
- pkaN/A
- LogD (pH=7, predicted)5.13
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)-5.09
- LogSw (predicted, AB/LogsW2.0)0.0
- Sw (mg/ml) (predicted, ACD/Labs)0.0
- No.of HBond Donors0
- No.of HBond Acceptors3
- No.of Rotatable Bonds6
- TPSA55.29
- StatusFDA approved
- AdministrationTopical
- PharmacologyAn antifungal medication of the imidazole class used to treat infections caused by a fungus or yeast.
- Absorption_valueN/A
- Absorption (description)Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmOrally administered tioconazole is extensively metabolized. The major metabolites are glucuronide conjugates.
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicitySymptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning, and general irritation of the skin, and cramps.
- LD50 (rat)N/A
- LD50 (mouse)N/A